Memantine Hydrochloride Rosemont Pharmaceuticals

Memantine Hydrochloride, the active ingredient in Memantine Hydrochloride Rosemont Pharmaceuticals, is a NMDA receptor antagonist presented as an oral tablet for oral use. It treats Alzheimer’s disease in adults. GNH USA supplies Memantine Hydrochloride Rosemont Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine Hydrochloride is an NMDA receptor antagonist used in the management of Alzheimer’s disease. - Alzheimer’s disease (mild to moderate): helps maintain cognition and functional abilities in affected adults.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Constipation - Confusion - Hypertension - Fatigue

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Hepatic dysfunction - Cardiac arrhythmias - Psychosis or severe agitation - Persistent vomiting

Memantine Hydrochloride requires careful consideration in several clinical situations. - Renal impairment: assess renal function and adjust dose if needed. - Hepatic impairment: monitor liver enzymes during therapy. - History of seizures: observe for increased seizure activity. - Concomitant NMDA antagonists: avoid combined use to reduce neurotoxicity risk. - Pregnancy: safety unknown; use only if benefits outweigh risks. - Store at ambient temperature: keep in original container, protect from moisture.

Memantine Hydrochloride can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neurotoxicity. - Strong CYP450 inhibitors (e.g., ketoconazole): may raise plasma levels. - Quinidine: can elevate memantine concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of edema. - Diuretics: can raise memantine plasma concentration. - Antihypertensives: additive blood pressure‑lowering effect.